We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.15%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$12.2B
AUM Growth
+$1.52B
(+14%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
9.66%
Top 10 Holdings %
Top 10 Hldgs %
19.97%
Holding
2,123
New
434
Increased
455
Reduced
367
Closed
827
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$197M |
| 2 |
Alibaba
BABA
|
+$190M |
| 3 |
Amazon
AMZN
|
+$161M |
| 4 |
GoDaddy
GDDY
|
+$135M |
| 5 |
Walt Disney
DIS
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 2 |
Zoetis
ZTS
|
+$96.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$69.5M |
| 4 |
Cadence Design Systems
CDNS
|
+$64.2M |
| 5 |
ANSS
Ansys
ANSS
|
+$60.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.88% |
| 2 | Consumer Discretionary | 23.99% |
| 3 | Technology | 11.1% |
| 4 | Financials | 8.14% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
226
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $12.5M | 0.1% |
285,961
+278,863
| +3,929% | +$15.7M |
|
227
American Electric Power
AEP
$72.4B
| $12.5M | 0.1% |
+142,224
| New | +$12.3M |
|
|
RWGE.U
228
DELISTED
Regalwood Global Energy Ltd. Units, each consisting of one Class A ordinary share and one-third of o
RWGE.U
| $12.5M | 0.1% |
1,200,000
| – | – |
|
229
Tenable Holdings
TENB
$3.46B
| $12.5M | 0.1% |
436,387
-25,175
| -5% | -$745K |
|
230
Red Rock Resorts
RRR
$3.87B
| $12.4M | 0.1% |
577,261
-298,257
| -34% | -$7.25M |
|
231
The RMR Group
RMR
$343M
| $12.4M | 0.1% |
263,852
+167,119
| +173% | +$9M |
|
|
MINI
232
DELISTED
Mobile Mini Inc
MINI
| $12.3M | 0.1% |
405,491
+294,688
| +266% | +$9.78M |
|
233
Perrigo
PRGO
$1.43B
| $12.3M | 0.1% |
258,289
+258,272
| +1,519,247% | +$12.3M |
|
234
Parker-Hannifin
PH
$125B
| $12.3M | 0.1% |
+72,175
| New | +$12.4M |
|
|
KEM
235
DELISTED
KEMET Corporation
KEM
| $12.2M | 0.1% |
651,219
-204,265
| -24% | -$3.57M |
|
236
Angi Inc
ANGI
$252M
| $12.1M | 0.1% |
92,689
+49,519
| +115% | +$7.63M |
|
237
Televisa
TV
$1.47B
| $12M | 0.1% |
1,421,078
+1,418,429
| +53,546% | +$13.8M |
|
238
Arcosa
ACA
$7.13B
| $12M | 0.1% |
317,820
-361,431
| -53% | -$12.4M |
|
239
Aramark
ARMK
$15.1B
| $11.8M | 0.1% |
454,805
+24,332
| +6% | +$569K |
|
|
SYNH
240
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $11.7M | 0.1% |
229,085
+52,036
| +29% | +$2.42M |
|
|
TRCO
241
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $11.5M | 0.1% |
249,690
+69,393
| +38% | +$3.21M |
|
242
United Parks & Resorts
PRKS
$2.21B
| $11.5M | 0.09% |
370,632
+353,458
| +2,058% | +$9.7M |
|
243
Insulet
PODD
$11.6B
| $11.5M | 0.09% |
+96,222
| New | +$9.87M |
|
|
CALY
244
Callaway Golf Company
CALY
$3.28B
| $11.5M | 0.09% |
667,316
-536,954
| -45% | -$8.87M |
|
|
HRC
245
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $11.4M | 0.09% |
109,423
-148,732
| -58% | -$15M |
|
246
Icon
ICLR
$13.9B
| $11.4M | 0.09% |
74,304
+63,233
| +571% | +$8.87M |
|
247
iShares 20+ Year Treasury Bond ETF
TLT
$43.1B
| $11.4M | 0.09% |
86,018
+36,362
| +73% | +$4.62M |
|
|
CVSA
248
Covista Inc
CVSA
$4.3B
| $11.2M | 0.09% |
+247,892
| New | +$11.4M |
|
|
BERY
249
DELISTED
Berry Global Group, Inc.
BERY
| $11.1M | 0.09% |
229,489
+89,560
| +64% | +$4.31M |
|
250
Ashland
ASH
$3.11B
| $11.1M | 0.09% |
138,235
-76,241
| -36% | -$5.89M |
|
Similar funds
Marshall Wace's Q2 2019 Portfolio in Review
As of Q2 2019, Marshall Wace held 2,123 positions worth $12.2B, up 14% from $10.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace deployed $1.17B of net new capital in Q2 2019, opening 434 new positions and adding to 455 existing holdings. Its largest new stake was EPAM Systems: 482,974 shares worth $83.6M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $122M trimmed.
- Marshall Wace's largest Q2 2019 buy was EPAM Systems: 482,974 shares worth $83.6M.
- Marshall Wace added most to Boston Scientific in Q2 2019, an estimated $197M increase.
- Marshall Wace's biggest Q2 2019 reduction was Alphabet (Google) Class A, cutting an estimated $122M.
- Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $69.5M.
- Marshall Wace's ten largest holdings make up 20% of its $12.2B portfolio in Q2 2019.
- Marshall Wace opened 434 new positions and closed 827 in Q2 2019.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $12.2B.
Based on Marshall Wace's 13F filing for Q2 2019, filed 14 Aug 2019.